Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL128243 | 0.94 | — | — | |
| Hydrochloric Acid SCHEMBL29212565 | 0.89 | — | — | |
| Hydrochloric Acid SCHEMBL8724865 | 0.89 | — | — | |
| SCHEMBL584765 | 0.84 | — | — | |
| SCHEMBL10708414 | 0.77 | — | — | |
| SCHEMBL7607985 | 0.74 | — | — | |
| SCHEMBL6264277 | 0.74 | — | — | |
| Sulfuric Acid SCHEMBL3230399 | 0.71 | CA5A (0.43) | — | |
| Dioxane SCHEMBL9160521 | 0.71 | TTR (0.43) | — | |
| Phosphonic Acid SCHEMBL28946025 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107216446-B | A kind of polymerization of catalyst/initiator system for being catalyzed initiation caprolactone polymerization and the caprolactone using it | 北京服装学院 | 2019-09-13 | — | — | CN | claimed |
| CN-109897072-A | A kind of polymerization of carbon monoxide-olefin polymeric and the caprolactone using the carbon monoxide-olefin polymeric containing iron complex and its preparation and comprising it | 北京服装学院 | 2019-06-18 | — | — | CN | claimed |
| CN-107216446-A | It is a kind of to be used to be catalyzed the catalyst/initiator system for triggering caprolactone polymerization and the polymerization using its caprolactone | 北京服装学院 | 2017-09-29 | — | — | CN | claimed |
| CN-109897072-B | Iron-containing complex, preparation thereof, catalyst composition containing iron-containing complex and polymerization of caprolactone by using catalyst composition | 北京服装学院 | 2021-05-18 | — | — | CN | disclosed |
| CN-109134229-B | Method for preparing cypress oleyl alcohol | 中国农业科学院农业环境与可持续发展研究所 | 2020-09-04 | — | — | CN | disclosed |
| CN-107216446-B | A kind of polymerization of catalyst/initiator system for being catalyzed initiation caprolactone polymerization and the caprolactone using it | 北京服装学院 | 2019-09-13 | — | — | CN | disclosed |
| CN-109897072-A | A kind of polymerization of carbon monoxide-olefin polymeric and the caprolactone using the carbon monoxide-olefin polymeric containing iron complex and its preparation and comprising it | 北京服装学院 | 2019-06-18 | — | — | CN | disclosed |
| CN-109134229-A | A method of preparing cypress oleyl alcohol | 中国农业科学院农业环境与可持续发展研究所 | 2019-01-04 | — | — | CN | disclosed |
| CN-107216446-A | It is a kind of to be used to be catalyzed the catalyst/initiator system for triggering caprolactone polymerization and the polymerization using its caprolactone | 北京服装学院 | 2017-09-29 | — | — | CN | disclosed |
| EP-2310371-B1 | PPAR AGONIST COMPOUNDS AND PREPARATION AND USES THEREOF FOR TREATING DIABETES AND/OR DYSLIPIDEMIA | GENFIT (FR) | 2013-05-15 | — | — | EP | disclosed |
| EP-2310371-A2 | PPAR AGONIST COMPOUNDS AND PREPARATION AND USES THEREOF FOR TREATING DIABETES AND/OR DYSLIPIDEMIA | Genfit (FR) | 2011-04-20 | — | — | EP | disclosed |
| CN-1524857-A | Tartrate salt of a substituted dipeptide as growth hormone secretagogue | �Ʒ� | 2004-09-01 | — | — | CN | disclosed |
| US-6596867-B2 | Bone disorders | PFIZER INC. | 2003-07-22 | — | — | US | disclosed |
| CN-1314912-A | Tartrate salt of substituted dipeptide as growth hormone secretagogue | PFIZER PROD INC (US) | 2001-09-26 | — | — | CN | disclosed |
| US-20010016570-A1 | Tartrate salt of a substituded dipeptide as growth hormone secretagogue | RAQUALIA PHARMA INC. (JP) | 2001-08-23 | — | — | US | disclosed |
| US-6248717-B1 | TREATMENT OF OSTEOPOROSIS, CARDIOTONIC AGENTS, ANTIAGING AGENTS, WOUND HEALING AGENTS | PFIZER INC. | 2001-06-19 | — | — | US | disclosed |
| EP-0989993-A1 | TARTRATE SALT OF A SUBSTITUTED DIPEPTIDE AS GROWTH HORMONE SECRETAGOGUE | Pfizer Products Inc. (US) | 2000-04-05 | — | — | EP | disclosed |
| WO-1998058948-A1 | TARTRATE SALT OF A SUBSTITUTED DIPEPTIDE AS GROWTH HORMONE SECRETAGOGUE | PFIZER PRODUCTS INC. (US) | 1998-12-30 | — | — | WO | disclosed |
| CN-1030704-C | Process for polymerizing monomers comprising at least one conjugated diene | ENICHEM ELASTOMERS (IT) | 1996-01-17 | — | — | CN | disclosed |
| CN-87103699-A | Molecular Weight Regulators for Lanthanide and Actinide Catalysts | — | 1988-09-21 | — | — | CN | disclosed |